These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
748 related articles for article (PubMed ID: 17517871)
1. Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection. Labaied M; Harupa A; Dumpit RF; Coppens I; Mikolajczak SA; Kappe SH Infect Immun; 2007 Aug; 75(8):3758-68. PubMed ID: 17517871 [TBL] [Abstract][Full Text] [Related]
2. The Micronemal Arredondo SA; Swearingen KE; Martinson T; Steel R; Dankwa DA; Harupa A; Camargo N; Betz W; Vigdorovich V; Oliver BG; Kangwanrangsan N; Ishino T; Sather N; Mikolajczak S; Vaughan AM; Torii M; Moritz RL; Kappe SHI Front Cell Infect Microbiol; 2018; 8():413. PubMed ID: 30547015 [TBL] [Abstract][Full Text] [Related]
3. Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. Tarun AS; Dumpit RF; Camargo N; Labaied M; Liu P; Takagi A; Wang R; Kappe SH J Infect Dis; 2007 Aug; 196(4):608-16. PubMed ID: 17624848 [TBL] [Abstract][Full Text] [Related]
4. First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers. Spring M; Murphy J; Nielsen R; Dowler M; Bennett JW; Zarling S; Williams J; de la Vega P; Ware L; Komisar J; Polhemus M; Richie TL; Epstein J; Tamminga C; Chuang I; Richie N; O'Neil M; Heppner DG; Healer J; O'Neill M; Smithers H; Finney OC; Mikolajczak SA; Wang R; Cowman A; Ockenhouse C; Krzych U; Kappe SH Vaccine; 2013 Oct; 31(43):4975-83. PubMed ID: 24029408 [TBL] [Abstract][Full Text] [Related]
5. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Silvie O; Rubinstein E; Franetich JF; Prenant M; Belnoue E; Rénia L; Hannoun L; Eling W; Levy S; Boucheix C; Mazier D Nat Med; 2003 Jan; 9(1):93-6. PubMed ID: 12483205 [TBL] [Abstract][Full Text] [Related]
6. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates. Annoura T; Ploemen IH; van Schaijk BC; Sajid M; Vos MW; van Gemert GJ; Chevalley-Maurel S; Franke-Fayard BM; Hermsen CC; Gego A; Franetich JF; Mazier D; Hoffman SL; Janse CJ; Sauerwein RW; Khan SM Vaccine; 2012 Mar; 30(16):2662-70. PubMed ID: 22342550 [TBL] [Abstract][Full Text] [Related]
7. CD81 is required for rhoptry discharge during host cell invasion by Plasmodium yoelii sporozoites. Risco-Castillo V; Topçu S; Son O; Briquet S; Manzoni G; Silvie O Cell Microbiol; 2014 Oct; 16(10):1533-48. PubMed ID: 24798694 [TBL] [Abstract][Full Text] [Related]
8. The intradermal route for inoculation of sporozoites of rodent malaria parasites for immunological studies. Inoue M; Culleton RL Parasite Immunol; 2011 Feb; 33(2):137-42. PubMed ID: 21226727 [TBL] [Abstract][Full Text] [Related]
9. Two Plasmodium 6-Cys family-related proteins have distinct and critical roles in liver-stage development. Annoura T; van Schaijk BC; Ploemen IH; Sajid M; Lin JW; Vos MW; Dinmohamed AG; Inaoka DK; Rijpma SR; van Gemert GJ; Chevalley-Maurel S; Kiełbasa SM; Scheltinga F; Franke-Fayard B; Klop O; Hermsen CC; Kita K; Gego A; Franetich JF; Mazier D; Hoffman SL; Janse CJ; Sauerwein RW; Khan SM FASEB J; 2014 May; 28(5):2158-70. PubMed ID: 24509910 [TBL] [Abstract][Full Text] [Related]
10. SAP1 is a critical post-transcriptional regulator of infectivity in malaria parasite sporozoite stages. Aly AS; Lindner SE; MacKellar DC; Peng X; Kappe SH Mol Microbiol; 2011 Feb; 79(4):929-39. PubMed ID: 21299648 [TBL] [Abstract][Full Text] [Related]
11. Plasmodium Cysteine Repeat Modular Proteins 3 and 4 are essential for malaria parasite transmission from the mosquito to the host. Douradinha B; Augustijn KD; Moore SG; Ramesar J; Mota MM; Waters AP; Janse CJ; Thompson J Malar J; 2011 Mar; 10():71. PubMed ID: 21453484 [TBL] [Abstract][Full Text] [Related]
12. Gene disruption of Plasmodium falciparum p52 results in attenuation of malaria liver stage development in cultured primary human hepatocytes. van Schaijk BC; Janse CJ; van Gemert GJ; van Dijk MR; Gego A; Franetich JF; van de Vegte-Bolmer M; Yalaoui S; Silvie O; Hoffman SL; Waters AP; Mazier D; Sauerwein RW; Khan SM PLoS One; 2008; 3(10):e3549. PubMed ID: 18958160 [TBL] [Abstract][Full Text] [Related]
13. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice. Aly AS; Downie MJ; Mamoun CB; Kappe SH Cell Microbiol; 2010 Jul; 12(7):930-8. PubMed ID: 20088947 [TBL] [Abstract][Full Text] [Related]
14. Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species. Silvie O; Greco C; Franetich JF; Dubart-Kupperschmitt A; Hannoun L; van Gemert GJ; Sauerwein RW; Levy S; Boucheix C; Rubinstein E; Mazier D Cell Microbiol; 2006 Jul; 8(7):1134-46. PubMed ID: 16819966 [TBL] [Abstract][Full Text] [Related]
15. Depletion of the Plasmodium berghei thrombospondin-related sporozoite protein reveals a role in host cell entry by sporozoites. Labaied M; Camargo N; Kappe SH Mol Biochem Parasitol; 2007 Jun; 153(2):158-66. PubMed ID: 17418435 [TBL] [Abstract][Full Text] [Related]
16. A new approach to generate a safe double-attenuated Plasmodium liver stage vaccine. Nagel A; Prado M; Heitmann A; Tartz S; Jacobs T; Deschermeier C; Helm S; Stanway R; Heussler V Int J Parasitol; 2013 May; 43(6):503-14. PubMed ID: 23500072 [TBL] [Abstract][Full Text] [Related]
17. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes. Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194 [TBL] [Abstract][Full Text] [Related]
18. Targeted deletion of SAP1 abolishes the expression of infectivity factors necessary for successful malaria parasite liver infection. Aly AS; Mikolajczak SA; Rivera HS; Camargo N; Jacobs-Lorena V; Labaied M; Coppens I; Kappe SH Mol Microbiol; 2008 Jul; 69(1):152-63. PubMed ID: 18466298 [TBL] [Abstract][Full Text] [Related]
19. Genetically modified Plasmodium parasites as a protective experimental malaria vaccine. Mueller AK; Labaied M; Kappe SH; Matuschewski K Nature; 2005 Jan; 433(7022):164-7. PubMed ID: 15580261 [TBL] [Abstract][Full Text] [Related]
20. Plasmodium berghei Δp52&p36 parasites develop independent of a parasitophorous vacuole membrane in Huh-7 liver cells. Ploemen IH; Croes HJ; van Gemert GJ; Wijers-Rouw M; Hermsen CC; Sauerwein RW PLoS One; 2012; 7(12):e50772. PubMed ID: 23227206 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]